All blog posts
Showing 60 out of 91 results
01 十一月 2023
Another chapter in the "pay for delay" saga: General Court rules on the Teva-Cephalon settlement agreement
22 九月 2023
Recent additions to Life Sciences Notes
22 九月 2023
The UK National Security and Investment regime: spotlight on pharma M&A
13 七月 2023
Navigating Contract Research Organisation Agreements: A legal perspective
05 六月 2023
HSF comments to JUVE Patent on expectations and aspirations for the UPC
01 六月 2023
The Unified Patent Court (UPC) starts today - 1 June 2023
19 五月 2023
HSF comments for Managing IP on Milan UPC Central Division confirmation
18 五月 2023
UPC central division cases that would have gone to the London seat under original UPC plans will be split between Paris and Munich seats initially
17 五月 2023
UPC central division cases that would have gone to the London seat under original UPC plans will be split between Paris and Munich seats initially
15 五月 2023
UPC publishes templates for court decisions and orders along with "non-binding" guidance
15 五月 2023
UPC Administrative Committee publishes guidance on case valuation methods, costs ceilings and court fees
28 四月 2023
Big changes ahead for medicinal products in the EU – EU regulatory framework and incentives set to change
Showing 60 out of 91 results
View moreKey contacts
Laura Orlando
Managing Partner, Milan Office, Milan
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London and India Group
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London and Africa Group